The CACNB2 gene is associated with autosomal dominant Brugada syndrome (BrS) (MedGen UID: 395632) and short QT syndrome (SQTS) (MedGen UID: 378835).
Order this gene as a single gene test.
Invitae tests that include this gene:
Pathogenic CACNB2 variants are a rare cause of BrS and SQTS.
The CACNB2 gene encodes the beta 2 subunit of voltage-dependent calcium channels, which control the flow of calcium ions in cardiac muscle. The electrical activity of cardiac muscle is controlled by the movement of potassium, sodium, and calcium ions across cardiac muscle cell membranes. Pathogenic variants in genes that encode subunits of the calcium channels are a common cause of inherited cardiac arrhythmias.
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence, and select noncoding variants. Our assay provides a Q30 quality-adjusted mean coverage depth of 350x (50x minimum, or supplemented with additional analysis). Variants classified as pathogenic or likely pathogenic are confirmed with orthogonal methods, except individual variants that have high quality scores and previously validated in at least ten unrelated samples.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|